Humacyte (HUMA) Other Accumulated Expenses (2023 - 2025)

Humacyte (HUMA) has 3 years of Other Accumulated Expenses data on file, last reported at $61000.0 in Q2 2025.

• Other Accumulated Expenses for Q2 2025 came in at $61000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $61000.0 (changed N/A YoY), and the FY2024 annual result was $238000.0, up 349.06% from the prior year.
• Other Accumulated Expenses grew to $61000.0 in Q2 2025 per HUMA's latest filing, from $60000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $238000.0 in Q4 2024 and troughed at $53000.0 in Q4 2023.
• A 3-year average of $103000.0 and a median of $60500.0 in 2025 frame the typical range for Other Accumulated Expenses.
• On a YoY basis, Other Accumulated Expenses climbed as much as 349.06% in 2024 and fell as far as 349.06% in 2024.
• A 3-year view of Other Accumulated Expenses shows it stood at $53000.0 in 2023, then soared by 349.06% to $238000.0 in 2024, then tumbled by 74.37% to $61000.0 in 2025.
• Business Quant data shows HUMA's Other Accumulated Expenses at $61000.0 in Q2 2025, $60000.0 in Q1 2025, and $238000.0 in Q4 2024.